Detection of Increased Activity of Human Parvovirus B19 Using Commercial Laboratory Testing of Clinical Samples and Source Plasma Donor Pools — United States, 2024
MMWR. Morbidity and Mortality Weekly Report · 28.11.2024 · 73 (47) · 1076-1081
DOI: 10.15585/mmwr.mm7347a2 ↗Kurz gefasst
Fachartikel in der Zeitschrift MMWR. Morbidity and Mortality Weekly Report, online erschienen am 28.11.2024. Verfasst von David Alfego und 11 weiteren Autor:innen. Hauptthemen laut MEDLINE: Parvovirus B19, Human, Parvoviridae Infections, Blood Donors. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
In most persons, human parvovirus B19 (B19) causes a mild respiratory illness, but infection can result in adverse health outcomes in persons who are pregnant, immunocompromised, or who have chronic hemolytic blood disorders. During the first quarter of 2024, several European countries reported increases in B19 activity. In the United States, there is no routine surveillance for B19. To assess increases in B19 activity in the United States, trends in testing and results from two independent populations were examined: 1) the presence of immunoglobulin (Ig) M antibodies, a marker of recent infection, in clinical specimens ordered by physicians and 2) B19 nucleic acid amplification testing (NAAT) in pooled donor source plasma from a large commercial laboratory during 2018-2024. The proportion of IgM-positive clinical specimens reached 9.9% in the second quarter (Q2) of 2024 after remaining
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Alfego, D., Hernandez-Romieu, A. C., Briggs-Hagen, M., Dietz, S., Gillim, L., Dale, S. E., Grover, A., Albrecht, J., Sesok-Pizzini, D., Eisenberg, M., Gregory, C. O., & Poirier, B. (2024). Detection of Increased Activity of Human Parvovirus B19 Using Commercial Laboratory Testing of Clinical Samples and Source Plasma Donor Pools — United States, 2024. MMWR. Morbidity and Mortality Weekly Report, 73(47), 1076-1081. https://doi.org/10.15585/mmwr.mm7347a2
Vancouver
Alfego D, Hernandez-Romieu AC, Briggs-Hagen M, Dietz S, Gillim L, Dale SE, et al. Detection of Increased Activity of Human Parvovirus B19 Using Commercial Laboratory Testing of Clinical Samples and Source Plasma Donor Pools — United States, 2024. MMWR. Morbidity and Mortality Weekly Report. 2024;73(47):1076-1081. doi:10.15585/mmwr.mm7347a2
BibTeX
@article{Alfego2024,
author = {Alfego, David and Hernandez-Romieu, Alfonso C and Briggs-Hagen, Melissa and Dietz, Stephanie and Gillim, Laura and Dale, Suzanne E and Grover, Ajay and Albrecht, Jeffrey and Sesok-Pizzini, Deborah and Eisenberg, Marcia and Gregory, Cria O and Poirier, Brian},
title = {Detection of Increased Activity of Human Parvovirus B19 Using Commercial Laboratory Testing of Clinical Samples and Source Plasma Donor Pools — United States, 2024},
journal = {MMWR. Morbidity and Mortality Weekly Report},
year = {2024},
volume = {73},
number = {47},
pages = {1076--1081},
doi = {10.15585/mmwr.mm7347a2}
}
EUVIMED